Over 11,000 participants from around the globe are once again expected at EuroPCR – a Course tailored for interventional cardiologists, cardiac surgeons, imaging specialists, radiologists, nurses, allied professionals and other practitioners, as well as researchers, innovators and industry representatives. They will be sharing their knowledge, skills and experience on interventions for coronary and peripheral vessels, valvular disease, heart failure, hypertension and stroke.
Course Directors Thomas Cuisset (FR), Nicolas Dumonteil (FR), PCR Co-Chairman Jean Fajadet (FR), Nieves Gonzalo (SP) and PCR Chairman William Wijns (IE) implemented comprehensive surveys of PCR Companions, nurses and allied professionals to ensure the Course is more than ever built by and for the community, and continues to meet the field’s constantly evolving educational needs.
The extensive 4-day scientific programme is an opportunity for participants at all stages of their career to improve their daily practice and to gain insights into the latest advancements in interventional cardiology.
A total of 66 Late-Breaking Trials and Hotlines will be presented in Paris. A dedicated Major Late-Breaking Trials at EuroPCR 2024 session will notably reveal three that have the potential to make a significant impact on current practice:
- First TAVI vs. SAVR randomised trial in younger low-risk patients with severe tricuspid or bicuspid aortic valve stenosis - results from NOTION-2 - O. De Backer
- One-month DAPT followed by 5-month Ticagrelor monotherapy in ACS with DCB - T. Ling
- Early outcomes of a randomised non-inferiority trial comparing TAVI devices: the LANDMARK trial - P. W. Serruys
More details can be found here:
29 simulation-based learning sessions in the Simulation Learning Rooms and the Hands On Lab will provide practical hands-on guidance, for procedures such as mitral transcatheter edge-to-edge repair, transseptal puncture, commissural alignment for TAVI, antegrade and retrograde CTO, echo-guidance of arterio-venous access/large bore access closure, and bifurcation PCI with upfront two-stent strategy.
Imaging guidance is an essential part of cardiovascular interventions, and the Course will shine a light this year on the key role of the Heart Team’s imagers. Participants will be able to enhance their OCT, IVUS, CT scan and multimodality imaging skills through a practical and hands-on approach, in “Focus on Imaging” sessions, covering both coronary and valvular interventions.
EuroPCR received a record-breaking 3,100+ submissions for this 2024 edition, with an acceptance rate of 65% and over 1,500 selected for onsite presentation in Paris.
12 LIVE Educational cases will be covering topics such as: calcified lesions, TAVI, left main stenosis, mitral transcatheter edge-to-edge repair, LAA closure, antegrade CTO, multivessel disease, and non-LM bifurcation. They will be broadcast from 8 LIVE Centres across the world:
- Johannesburg, South Africa - Netcare Sunninghill Hospital
- Leipzig, Germany - Heart Center
- Madrid, Spain - Hospital Clínico San Carlos
- Mainz, Germany - University Medical Center
- Massy, France - Cardiovascular Institute Paris Sud
- Poznan, Poland - University of Medical Sciences
- Rome, Italy - Policlinico Universitario Fondazione Agostino Gemelli
- Toulouse, France - Clinique Pasteur
Worldwide outreach is further enhanced by the active involvement of 68 National Societies and Working Groups in 23 joint sessions. An additional 6 collaborative sessions will also be providing an opportunity to compare and learn from the sharing of diverse global practices.
The EuroPCR programme will also offer content with a focus on the NextGen, including Learning sessions on the essentials of bifurcation PCI, OCT, CTO, IVUS, TAVI and rotational atherectomy, as well as a must-see session on 3D cardiac anatomy and another on cases with treatment dilemmas.
Participants will find 9 sessions tailored by and for Nurses and Allied Professionals. Topics have been inspired by a new survey among the community and include: evidence in clinical practice, MINOCA, femoral access, structural heart interventions, how to train staff as well as inform/educate patients, and a session on the taboo of mental health in the cathlab.
Two additional Courses will be taking place the day before EuroPCR, on 13 May 2024:
PCR Innovators Day connects the key stakeholders in innovation in the cardiovascular community, and reflects on what will be the field’s next big thing. This year’s innovation presentations will focus on valves, heart failure and renal denervation, with a reward for the best innovation donated by the Jon DeHaan Foundation.
The EAPCI-PCR Fellows Course will enable early career practitioners to actively engage in dedicated case-based sessions and benefit from unique networking opportunities. The 2024 programme includes three-vessel disease, STEMI, left main and calcified stenosis, as well as a session on presentation skills.
NOTES TO EDITORS
About EuroPCR 2024
The World-Leading Course in interventional cardiovascular medicine and the official annual meeting of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) will take place from 14 to 17 May 2024, onsite at the Palais des Congrès, Paris, France. A digital package is also available for those unable to join in person.
The detailed Course Programme is available on: https://www.pcronline.com/Courses/EuroPCR/Programme
About PCR
The mission of PCR is to serve the needs of each individual patient by helping the global cardiovascular community to share knowledge, experience and practice. PCR offers a large range of many other educational meetings and resources for the continuing education of the interventional cardiovascular community. These include major annual courses across the globe, e-learning with high-profile PCR Webinars, courses specifically dedicated to valvular heart disease, tailor-made PCR Seminars on specific topics, online resources and medical publications such as EuroIntervention, the official journal of the EAPCI.
Gateways to all PCR activities are available on www.pcronline.com.
For further information, please contact Sally Collingridge: scollingridge@europa-group.com
About the EAPCI
The European Association of Percutaneous Cardiovascular Interventions (EAPCI) is a branch of the European Society of Cardiology. Its mission is to reduce the burden of cardiovascular disease through percutaneous cardiovascular interventions. This dynamic association represents a large community of over 8K EAPCI associates and over 1K full EAPCI members by helping them remain up to date in the constantly evolving field of PCI by publishing research and providing educational, training and certification programmes. The EAPCI also advocates for the best possible access to life saving treatments for patients through data-based advocacy at a European level.
HELP FOR JOURNALISTS TO COVER EUROPCR 2024
Register and attend EuroPCR 2024 as a journalist
Open to accredited journalists, free of charge. Journalists must hold a valid press card and/or provide a letter of assignment from a recognised publication. To register as press, go to
https://www.pcronline.com/Courses/EuroPCR/Press
EuroPCR press releases can be found at
https://www.pcronline.com/News/PCR-Press-Releases.
For any press-related enquiries, please contact
EuroPCR Press Coordinator, Isabelle Uzielli: iuzielli@europcr.com